IHC illustrates that the percentage of cell expressing SCEL were 22.7%, 42.1%, 64.2%, and 63% in cancer stage I, II, III, and IV of CRC, respectively (Figure 4A), revealing SCEL expression correlates with cancer malignancy. The gene discussed is SCEL; the disease is cancer.